1979
DOI: 10.1128/jcm.9.5.609-614.1979
|View full text |Cite
|
Sign up to set email alerts
|

Development of dengue virus plaques under serum-free overlay medium

Abstract: An improved plaque assay for dengue virus was developed utilizing baby hamster kidney (BHK-21) cells initially grown in shaker culture. Different media preparations were tested for uniform and fast formation of BHK-21 cell sheets. Several overlay formulas were tested to develop a rapid plaque assay in 6- and 24-well plastic plates. The best results were obtained utilizing Eagle minimal essential medium (pH 7.2 to 7.4) supplemented with 1 mg of NaHCO3 per ml and 5% newborn calf serum for the formation of cell m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
1
0

Year Published

1981
1981
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(4 citation statements)
references
References 21 publications
(26 reference statements)
0
1
0
Order By: Relevance
“…In this study, we used Vero and BHK-21 cells as they are susceptible to DENV infection. In previous in vitro studies, various host cells, including BHK-2 16 , Vero 17 , Vero E6 18 , Huh-7 19 , and A549 14 cells, have been used for DENV infection. The antiviral agent ribavirin is currently used as the preferred treatment against infection by DENV 20 , 21 , ZIKV 21 , 22 , and hepatitis C virus (HCV) 23 .…”
Section: Discussionmentioning
confidence: 99%
“…In this study, we used Vero and BHK-21 cells as they are susceptible to DENV infection. In previous in vitro studies, various host cells, including BHK-2 16 , Vero 17 , Vero E6 18 , Huh-7 19 , and A549 14 cells, have been used for DENV infection. The antiviral agent ribavirin is currently used as the preferred treatment against infection by DENV 20 , 21 , ZIKV 21 , 22 , and hepatitis C virus (HCV) 23 .…”
Section: Discussionmentioning
confidence: 99%
“…In addition, the cell suspensions collected in the kinetics were titrated by plaque assay on Vero cells using a protocol adapted from Malewicz and Jenkin, 1979 [ 32 ]. Titration was performed to compare the SLEV titer in the SLEV-positive control and co-infection conditions.…”
Section: Methodsmentioning
confidence: 99%
“…They were then observed daily under an inverted optical microscope, and when they showed a cytopathic effect, they were frozen at −80 • C in a freezer. After this, aliquots of 100 µL of this material were created in Eppendorf tubes to be stored in a freezer at −80 • C. Subsequently, the viral titer of SLEV was obtained by plaque assay, and the titer of BREV was obtained by TCID 50 [32,33]. To use the titer values (PFU/mL) in the MOI formula, we transformed the BREV titer from TCID 50 / mL to PFU/mL using the formula TCID 50 /mL titer × 0.7 = titer in PFU/mL [34].…”
Section: Preparation and Titration Of The Viral Stockmentioning
confidence: 99%
“…Two animals ( n = 2) were isolated to compose the control group (G1) and inoculated with a 0.5 mL suspension of strain-free VERO cells (ATCC number CCL-81, Washington, DC, USA). The other animals (G2; n = 3) were experimentally infected by the Asian genotype of ZIKV, strain BE H815744 (Genbank KU365780) isolated by Department of Arbovirology and Hemorrhagic Fevers, Evandro Chagas Institute, Ananindeua, Brazil, the inoculum with a 0.5 mL suspension of infected VERO cells containing 1.0 × 10 5 PFU/mL via intradermal injection at the level of the third right intercostal space below the right nipple [ 34 ] ( Figure 1 ).…”
Section: Methodsmentioning
confidence: 99%